
Steel City Pharmaceuticals Pvt Ltd
Sells medicines and pharmaceutical products.
Sells medicines and pharmaceutical products.
Steel City Pharmaceuticals Pvt Ltd (SCPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 28 December 1993 and has a history of 31 years and two months. Its registered office is in Visakhapatnam, Andhra Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.61 M.
The company currently has active open charges totaling ₹0.50 M.
Veeru Manthini, Satyanarayana Chaparala, Rama Vemulapalli, and Four other members serve as directors at the Company.
Visakhapatnam, Andhra Pradesh, India
+91-XXXXXXXXXX
U24239AP1993PTC016799
016799
Private Limited Indian Non-Government Company
28 Dec 1993
30 Sep 2024
31 Mar 2024
Unlisted
Roc Vijayawada
Name | Designation | Appointment Date | Status |
---|---|---|---|
Veeru Manthini ![]() | Managing Director | 01-Oct-2002 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Satyanarayana Chaparala ![]() | Director | 12-Aug-2016 | Current |
Rama Vemulapalli ![]() | Director | 30-Sep-2006 | Current |
Thirupathi Bommi ![]() | Director | 28-Mar-2012 | Current |
Narasimharaju Datlavenkata ![]() | Director | 28-Mar-2012 | Current |
Surya Kakarlapudi ![]() | Director | 12-Aug-2016 | Current |
Papa Vegi ![]() | Director | 30-Sep-2008 | Current |
Steel City Pharmaceuticals Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 12.41% increase. The company also saw a slight improvement in profitability, with a 2.42% increase in profit. The company's net worth dipped by a decrease of 5.62%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2019, Steel City Pharmaceuticals had a promoter holding of 11.99% and a public holding of 88.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Veeru Manthini, Rama Vemulapalli and 2 more are mutual person
Narasimharaju Datlavenkata and Papa Vegi are mutual person
Narasimharaju Datlavenkata and Papa Vegi are mutual person
Narasimharaju Datlavenkata and Papa Vegi are mutual person
Narasimharaju Datlavenkata and Papa Vegi are mutual person
₹0.05 Cr
₹0
Date | Lender | Amount | Status |
---|---|---|---|
10 May 1995 | The Lakshmi Vilas Bank Limited | ₹0.50 M | Open |
Unlock and access historical data on people associated with Steel City Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Steel City Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Steel City Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Steel City Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Steel City Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada.
Satyanarayana Chaparala was appointed as a Director was appointed as a Director on 12 Aug 2016 & has been associated with this company since 8 years 6 months .
Surya Sita Rama Raju Kakarlapudi was appointed as a Director was appointed as a Director on 12 Aug 2016 & has been associated with this company since 8 years 6 months .
Thirupathi Rao Bommi was appointed as a Director was appointed as a Director on 28 Mar 2012 & has been associated with this company since 12 years 11 months .
Narasimharaju Datlavenkata was appointed as a Director was appointed as a Director on 28 Mar 2012 & has been associated with this company since 12 years 11 months .
Steel City Pharmaceuticals Pvt Ltd was incorporated on 28 Dec 1993.
The authorized share capital of Steel City Pharmaceuticals Pvt Ltd is ₹ 1.00 Cr and paid-up capital is ₹ 9.61 M.
Currently 7 directors are associated with Steel City Pharmaceuticals Pvt Ltd.
As per Ministry of Corporate Affairs (Mca), the registered address of Steel City Pharmaceuticals Pvt Ltd is 13-8-4/1 1St Floor Steelcity Bhavan B.C. Road, New Gajuwaka India, Visakhapatnam, Andhra Pradesh, 530026.
The corporate identification number (CIN) of Steel City Pharmaceuticals Pvt Ltd is U24239AP1993PTC016799 and the company number is 016799 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Steel City Pharmaceuticals Pvt Ltd has risen by 12.41%.
The financial reports for the fiscal year 2022 indicates that The net worth of Steel City Pharmaceuticals Pvt Ltd has experienced an downturn of -5.62%.
As per the financial statements for fiscal Year 2022, The total open charges for Steel City Pharmaceuticals Pvt Ltd amount to ₹ 0.50 M.
The most recent Balance Sheet for Steel City Pharmaceuticals Pvt Ltd was filed with the ROC on 31 Mar 2024.
SY
JK
SD
PP
NL
SB